Xolair 75 MG/0.5 ML syringe 0.5ML

Ended Awarded

Contract number
SPE2DB23FYQ30
Awardee
Awarding agency
Obligated
$11,606

Award facts

Contract value 100% obligated
$11,605.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a $11,605.50 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561367155 XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The contract will be performed in Park Ridge, Illinois between June 26, 2023 and July 18, 2023. As the DLA supports the Department of Defense by procuring food, clothing, medicines, fuel and other necessary supplies, this delivery order will provide the military with Xolair, a medication used to treat asthma and chronic idiopathic urticaria. No set aside designation or subcontracting details were indicated.

Quick answers

Who was awarded contract SPE2DB23FYQ30?

SPE2DB23FYQ30 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 26, 2023.

How much is contract SPE2DB23FYQ30 worth?

The government has obligated $11,606 on SPE2DB23FYQ30.

Is contract SPE2DB23FYQ30 an order under another contract?

Yes. SPE2DB23FYQ30 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.

Was contract SPE2DB23FYQ30 competed?

The extent of competition for SPE2DB23FYQ30 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award